DZ2714A1 - Traitement du mal fonctionnement sexuel féminin. - Google Patents

Traitement du mal fonctionnement sexuel féminin.

Info

Publication number
DZ2714A1
DZ2714A1 DZ990015A DZ990015A DZ2714A1 DZ 2714 A1 DZ2714 A1 DZ 2714A1 DZ 990015 A DZ990015 A DZ 990015A DZ 990015 A DZ990015 A DZ 990015A DZ 2714 A1 DZ2714 A1 DZ 2714A1
Authority
DZ
Algeria
Prior art keywords
treatment
sexual dysfunction
female sexual
female
dysfunction
Prior art date
Application number
DZ990015A
Other languages
English (en)
French (fr)
Inventor
Regab El-Rashidy
Bruce Ronsen
Original Assignee
Pentech Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentech Pharmaceuticals Inc filed Critical Pentech Pharmaceuticals Inc
Application granted granted Critical
Publication of DZ2714A1 publication Critical patent/DZ2714A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DZ990015A 1998-01-30 1999-01-30 Traitement du mal fonctionnement sexuel féminin. DZ2714A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/016,252 US5945117A (en) 1998-01-30 1998-01-30 Treatment of female sexual dysfunction

Publications (1)

Publication Number Publication Date
DZ2714A1 true DZ2714A1 (fr) 2003-09-01

Family

ID=21776169

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990015A DZ2714A1 (fr) 1998-01-30 1999-01-30 Traitement du mal fonctionnement sexuel féminin.

Country Status (34)

Country Link
US (2) US5945117A (no)
EP (1) EP1056419A4 (no)
JP (1) JP2002501875A (no)
KR (1) KR20010040477A (no)
CN (1) CN1250221C (no)
AR (1) AR017976A1 (no)
AU (1) AU752928B2 (no)
BG (1) BG64667B1 (no)
BR (1) BR9908038A (no)
CA (1) CA2322289A1 (no)
CO (1) CO4970819A1 (no)
CR (1) CR5959A (no)
DZ (1) DZ2714A1 (no)
GC (1) GC0000096A (no)
GT (1) GT199900013A (no)
HK (1) HK1040901B (no)
HN (1) HN1999000015A (no)
HU (1) HUP0101268A3 (no)
IL (2) IL137569A0 (no)
JO (1) JO2085B1 (no)
MA (1) MA26600A1 (no)
MX (1) MXPA00007447A (no)
NO (1) NO319821B1 (no)
NZ (1) NZ506597A (no)
PA (1) PA8467801A1 (no)
PE (1) PE20000240A1 (no)
PL (1) PL194350B1 (no)
SK (1) SK11362000A3 (no)
TN (1) TNSN99008A1 (no)
TR (1) TR200002220T2 (no)
TW (1) TW550069B (no)
UY (1) UY25374A1 (no)
WO (1) WO1999038467A1 (no)
ZA (1) ZA99686B (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020165122A1 (en) * 1994-04-22 2002-11-07 Heaton Jeremy P. W. Method and compositions for the treatment or amelioration of female sexual dysfunction
US6395744B1 (en) * 1994-04-22 2002-05-28 Queen's University At Kingston Method and compositions for the treatment or amelioration of female sexual dysfunction
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
AU2003204720B2 (en) * 1998-05-29 2006-06-29 Tap Pharmaceutical Products Inc. Methods for the normalization of sexual response and amelioration of long term genital tissue degradation
MXPA01000275A (es) * 1998-06-22 2002-04-24 Univ Kingston Metodo y composiciones para el tratamiento o alivio de disfunciones sexuales femeninas.
US20050245494A1 (en) * 1999-07-01 2005-11-03 40 J's Llc Methods to treat one or all of the defined etiologies of female sexual dysfunction
US20050070499A1 (en) * 1999-11-08 2005-03-31 Pfizer Inc. Compounds for the treatment of female sexual dysfunction
BR0005797A (pt) * 2000-03-20 2001-10-16 Abbott Lab Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados
JP2003532640A (ja) * 2000-04-07 2003-11-05 タツプ・フアーマシユーテイカル・プロダクツ・インコーポレイテツド アポモルヒネ誘導体及びその使用方法
DE60131644T2 (de) 2000-05-09 2008-10-30 Nitromed, Inc., Lexington Infrarotthermographie und behandlung von sexuellen dysfunktionen
CA2417552C (en) 2000-06-27 2014-05-13 Qualilife Pharmaceuticals Inc. Compositions and methods for treating females sexual response
WO2002007757A2 (en) * 2000-07-21 2002-01-31 Lue Tom F Prevention and treatment of sexual arousal disorders
US7223406B2 (en) * 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
CZ20031540A3 (cs) 2000-11-15 2004-05-12 Tapápharmaceuticaláproductsźáinc Léčivo pro léčení sexuální dysfunkce
BR0110450A (pt) * 2000-11-22 2005-02-09 Abbott Lab Uso de agonistas receptores d4 de dopamina seletivo para tratamento de disfunção sexual
MXPA03007081A (es) * 2001-02-08 2004-10-15 Pharmacia Corp Medicamento de accion rapida para el tratamiento de disfuncion sexual.
BR0308567A (pt) * 2002-03-19 2007-01-09 Michael Holick derivados de glicosìdeo e glicosìdeo de ortoéster de apomorfina, análogos, e seus usos
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
GB0221711D0 (en) * 2002-09-19 2002-10-30 Ardana Bioscience Ltd Methods
CA2445212A1 (en) * 2002-10-10 2004-04-10 Queen's University At Kingston Treatment of sexual dysfunction
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
AU2004228757A1 (en) * 2003-04-14 2004-10-21 Vectura Ltd Pharmaceutical compositions comprising apomorphine for pulmonary inhalation
US20040204439A1 (en) * 2003-04-14 2004-10-14 Staniforth John Nicholas Composition, device, and method for treating sexual dysfunction via inhalation
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US7306812B2 (en) 2003-05-09 2007-12-11 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
GB0314054D0 (en) * 2003-06-17 2003-07-23 Pfizer Ltd Amide derivatives as selective serotonin re-uptake inhibitors
US20050054688A1 (en) * 2003-08-08 2005-03-10 Pfizer Inc Selective serotonin reuptake inhibitors in the treatment of disease
DE10338174A1 (de) * 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
MXPA06012505A (es) * 2004-04-30 2006-12-15 Warner Lambert Co Compuestos de morfolina sustituida para el tratamiento de trastornos del sistema nervioso central.
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
EP1863484A1 (en) * 2005-03-21 2007-12-12 Pfizer Limited Substituted triazole derivatives as oxytocin antagonists
DE602006003416D1 (de) * 2005-03-21 2008-12-11 Pfizer Ltd Substituierte triazolderivate als oxytocinantagonisten
NZ562311A (en) * 2005-04-08 2009-10-30 Ozpharma Pty Ltd Buccal delivery system
US20100222365A1 (en) * 2005-08-10 2010-09-02 Pfizer Inc Substituted triazole deriviatives as oxytocin antagonists
EP2233472B1 (en) * 2006-03-28 2014-01-15 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
US7800094B2 (en) * 2007-06-11 2010-09-21 Macronix International Co., Ltd. Resistance memory with tungsten compound and manufacturing
DK2952191T3 (en) 2009-06-12 2018-12-10 Sunovion Pharmaceuticals Inc Sublingual apomorphine
US20130210867A1 (en) * 2010-04-15 2013-08-15 Life Science Enhancement Corporation Methods and compositions for enhancing female sexual arousal and treating female sexual dysfunction
CA3116942A1 (en) 2010-12-16 2012-06-21 Sunovion Pharmaceuticals Inc. Sublingual films comprising apomorphine and an organic base
EP2697206B1 (en) 2011-04-10 2019-04-03 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
EP2545905A1 (en) 2011-07-11 2013-01-16 Britannia Pharmaceuticals Limited A new therapeutical composition containing apomorphine as active ingredient
CA3127926A1 (en) 2015-04-21 2016-10-27 Sunovion Pharmaceuticals Inc. Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
AU4312593A (en) * 1992-05-18 1993-12-13 Smithkline Beecham Plc Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
KR100374924B1 (ko) * 1994-04-22 2003-07-22 퀸스 유니버시티 엣 킹스톤 남성발기기능장애를회복시키고진단하기위한설하용량형
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction

Also Published As

Publication number Publication date
BR9908038A (pt) 2002-01-02
NO319821B1 (no) 2005-09-19
CN1313742A (zh) 2001-09-19
IL137569A (en) 2006-08-01
AR017976A1 (es) 2001-10-24
HK1040901A1 (en) 2002-06-28
CA2322289A1 (en) 1999-08-05
TNSN99008A1 (fr) 2005-11-10
EP1056419A4 (en) 2007-05-02
GC0000096A (en) 2005-06-29
IL137569A0 (en) 2001-07-24
CO4970819A1 (es) 2000-11-07
MA26600A1 (fr) 2004-12-20
AU752928B2 (en) 2002-10-03
PL194350B1 (pl) 2007-05-31
SK11362000A3 (sk) 2001-02-12
AU2564499A (en) 1999-08-16
EP1056419A1 (en) 2000-12-06
ZA99686B (en) 1999-07-28
NO20003845D0 (no) 2000-07-27
CR5959A (es) 1999-07-28
BG104715A (bg) 2001-02-28
PA8467801A1 (es) 2000-09-29
TR200002220T2 (tr) 2000-12-21
KR20010040477A (ko) 2001-05-15
NZ506597A (en) 2003-07-25
TW550069B (en) 2003-09-01
NO20003845L (no) 2000-09-28
US6193992B1 (en) 2001-02-27
GT199900013A (es) 2001-07-20
BG64667B1 (bg) 2005-11-30
MXPA00007447A (es) 2006-01-25
US5945117A (en) 1999-08-31
JO2085B1 (en) 2000-05-21
PE20000240A1 (es) 2000-03-31
CN1250221C (zh) 2006-04-12
PL342062A1 (en) 2001-05-21
HK1040901B (zh) 2006-11-24
UY25374A1 (es) 1999-09-27
HN1999000015A (es) 1999-08-23
WO1999038467A1 (en) 1999-08-05
JP2002501875A (ja) 2002-01-22
HUP0101268A2 (hu) 2001-09-28
HUP0101268A3 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
DZ2714A1 (fr) Traitement du mal fonctionnement sexuel féminin.
IS2494B (is) Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni
DE69918222D1 (de) Intranasale Zubereitungen zur Behandlung sexueller Störungen
IL153492A0 (en) Treatment of male sexual dysfunction
PT1073658E (pt) Inibidores de ogmp pdes de pirazolopirimidinona para o tratamento da disfuncao sexual
ID30276A (id) Metode untuk mengobati gangguan-gangguan seksual
DE60103770D1 (de) Botulinumtoxin zur behandlung endokriner erkrankungen
CH1143977H1 (fr) 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
PL359726A1 (en) Animal device for collecting an animal's seminal fluid
DE60105614D1 (de) Oxazinochinolone für die behandlung viraler infektionen
MA26835A1 (fr) Traitement de l'emphyseme utilisant des agonistes retinoides selectifs des rar.
NO20024442D0 (no) Behandling av seksuell dysfunksjon med apomorfin
NO20032189D0 (no) Behandling av antidepresjonsmiddel-indusert seksuell dysfunksjon med apomorfin
NO20030978D0 (no) Behandling av diuresedysfunksjon
DE50009813D1 (de) Kombinationpräparat zur behandlung von sexueller dysfunktion
PL362980A1 (en) Treatment of sexual dysfunction
ATE302008T1 (de) Behandlung von entzündlichen erkrankungen
DE60122601D1 (de) Behandlung von entzündlichen Darmerkrankungen
FR2765214B1 (fr) Traitement de granulat par un latex anti-desenrobage
EA200200927A1 (ru) Способ профилактики и лечения заболеваний иммунной системы и средство для его осуществления
KR970023740U (ko) 좌변기 배수관의 편심연결장치
RU2002106131A (ru) Способ зачатия
GB0011926D0 (en) Treatment of sexual dysfunction
KR960030459U (ko) 성기능 강화 링
PL317979A1 (en) Erotic sexual intercourse enhanced for use by men